CAD 0.01
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -9.34 Million CAD | -50.2% |
2022 | -4.8 Million CAD | -44.71% |
2021 | -3.32 Million CAD | 80.02% |
2020 | -16.63 Million CAD | -66.85% |
2019 | -9.96 Million CAD | -207.92% |
2018 | -3.23 Million CAD | -27.15% |
2017 | -2.54 Million CAD | 30.71% |
2016 | -3.67 Million CAD | -8897.33% |
2015 | -40.84 Thousand CAD | 0.0% |
2013 | -1.03 Million CAD | -387.34% |
2012 | -211.43 Thousand CAD | 62.76% |
2011 | -567.77 Thousand CAD | -273.53% |
2010 | -152 Thousand CAD | -148.9% |
2009 | -61.07 Thousand CAD | -105.55% |
2008 | -29.71 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | -365.79 Thousand CAD | -6.37% |
2024 Q2 | 670.36 Thousand CAD | 961.7% |
2024 Q1 | 63.14 Thousand CAD | 101.58% |
2023 FY | -7.22 Million CAD | -50.2% |
2023 Q1 | -334.04 Thousand CAD | 89.99% |
2023 Q2 | 414.7 Thousand CAD | 224.15% |
2023 Q3 | -2.94 Million CAD | -809.19% |
2023 Q4 | -4 Million CAD | -36.24% |
2022 Q1 | -482.33 Thousand CAD | 62.81% |
2022 FY | -4.8 Million CAD | -44.71% |
2022 Q3 | -282.45 Thousand CAD | 59.95% |
2022 Q4 | -3.33 Million CAD | -1081.76% |
2022 Q2 | -705.26 Thousand CAD | -46.22% |
2021 Q4 | -1.29 Million CAD | -224.93% |
2021 Q3 | 1.03 Million CAD | 204.87% |
2021 FY | -3.32 Million CAD | 80.02% |
2021 Q2 | -989.98 Thousand CAD | 52.26% |
2021 Q1 | -2.07 Million CAD | 54.04% |
2020 FY | -16.63 Million CAD | -66.85% |
2020 Q1 | -2.87 Million CAD | 3.53% |
2020 Q2 | -5.5 Million CAD | -91.84% |
2020 Q3 | -3.73 Million CAD | 32.15% |
2020 Q4 | -4.51 Million CAD | -20.69% |
2019 Q2 | -1.39 Million CAD | 45.9% |
2019 Q4 | -2.97 Million CAD | 4.03% |
2019 FY | -9.96 Million CAD | -207.92% |
2019 Q1 | -2.58 Million CAD | -35.92% |
2019 Q3 | -3.1 Million CAD | -122.25% |
2018 Q1 | -530.4 Thousand CAD | 70.93% |
2018 FY | -3.23 Million CAD | -27.15% |
2018 Q4 | -1.89 Million CAD | -576.99% |
2018 Q3 | -280.37 Thousand CAD | 51.23% |
2018 Q2 | -574.95 Thousand CAD | -8.4% |
2017 Q1 | -113.29 Thousand CAD | 94.03% |
2017 Q4 | -1.82 Million CAD | -234.17% |
2017 FY | -2.54 Million CAD | 30.71% |
2017 Q3 | -545.98 Thousand CAD | -128.36% |
2017 Q2 | -239.09 Thousand CAD | -111.04% |
2016 Q2 | -722.81 Thousand CAD | -284.44% |
2016 Q1 | -188.01 Thousand CAD | -385.89% |
2016 FY | -3.67 Million CAD | -8897.33% |
2016 Q4 | -1.89 Million CAD | -721.84% |
2016 Q3 | -230.75 Thousand CAD | 68.08% |
2015 Q4 | -38.69 Thousand CAD | 33.32% |
2015 FY | -40.84 Thousand CAD | 0.0% |
2015 Q3 | -58.03 Thousand CAD | -166.91% |
2015 Q2 | -21.74 Thousand CAD | -151.36% |
2015 Q1 | -8650.00 CAD | 80.86% |
2014 Q3 | -16.45 Thousand CAD | 98.31% |
2014 Q4 | -45.19 Thousand CAD | -174.57% |
2014 Q1 | -16.61 Thousand CAD | -35.44% |
2014 Q2 | -973.82 Thousand CAD | -5761.48% |
2013 Q3 | -27.71 Thousand CAD | 76.06% |
2013 Q4 | -12.26 Thousand CAD | 55.75% |
2013 FY | -1.03 Million CAD | -387.34% |
2013 Q1 | -39.59 Thousand CAD | -60.95% |
2013 Q2 | -115.79 Thousand CAD | -192.47% |
2012 Q4 | -24.59 Thousand CAD | 21.8% |
2012 Q1 | -52.57 Thousand CAD | 49.32% |
2012 Q2 | -188.59 Thousand CAD | -258.74% |
2012 Q3 | -31.45 Thousand CAD | 83.32% |
2012 FY | -211.43 Thousand CAD | 62.76% |
2011 Q2 | -97.04 Thousand CAD | -169.05% |
2011 Q4 | -103.74 Thousand CAD | 53.45% |
2011 Q3 | -222.87 Thousand CAD | -129.67% |
2011 FY | -567.77 Thousand CAD | -273.53% |
2011 Q1 | -36.06 Thousand CAD | -343.82% |
2010 Q2 | -23.5 Thousand CAD | -12.69% |
2010 FY | -152 Thousand CAD | -148.9% |
2010 Q4 | -8127.00 CAD | 24.51% |
2010 Q3 | -10.76 Thousand CAD | 54.21% |
2010 Q1 | -20.85 Thousand CAD | -248.87% |
2009 Q1 | -17.5 Thousand CAD | 0.0% |
2009 Q4 | -5979.00 CAD | 44.26% |
2009 Q3 | -10.72 Thousand CAD | 0.0% |
2009 FY | -61.07 Thousand CAD | -105.55% |
2008 FY | -29.71 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | -685.03% |
Ayurcann Holdings Corp. | -3.25 Million CAD | -187.593% |
Blueberries Medical Corp. | -1.22 Million CAD | -662.232% |
The BC Bud Corporation | -1.22 Million CAD | -664.158% |
BioNxt Solutions Inc. | -6.36 Million CAD | -46.833% |
CordovaCann Corp. | -2.51 Million CAD | -272.103% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -961.761% |
Captor Capital Corp. | 655.2 Thousand CAD | 1526.921% |
City View Green Holdings Inc. | -996.45 Thousand CAD | -838.262% |
1CM Inc. | 300.79 Thousand CAD | 3208.242% |
Global Hemp Group Inc. | -551.7 Thousand CAD | -1594.612% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | -141.018% |
IM Cannabis Corp. | -12.17 Million CAD | 23.209% |
Lobe Sciences Ltd. | -3.35 Million CAD | -178.304% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -2283.715% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | -193.45% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 1824.106% |
Ovation Science Inc. | -764 Thousand CAD | -1123.719% |
Pharmadrug Inc. | -1.33 Million CAD | -600.316% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | -718.697% |
RAMM Pharma Corp. | -7.08 Million CAD | -31.938% |
RIV Capital Inc. | 1.78 Million CAD | 625.172% |
Revive Therapeutics Ltd. | -3.28 Million CAD | -184.516% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | -6.617% |
SLANG Worldwide Inc. | -5.98 Million CAD | -56.176% |
Red Light Holland Corp. | -6.44 Million CAD | -45.031% |
Top Strike Resources Corp. | -784.8 Thousand CAD | -1091.296% |
Xebra Brands Ltd. | -1.55 Million CAD | -501.421% |
Adastra Holdings Ltd. | -1.79 Million CAD | -421.213% |